Download This PaperAfter Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?
35 Nature Biotechnology 820-825
31 Pages Posted: 22 May 2018
Date Written: September 11, 2017
Abstract
Using a novel research method, this paper examines the types of claim amendments that have transformed isolated gene claims from patent-ineligible into eligible subject matter. It also provides clarity into the threshold of eligibility for gene-related patents.
Keywords: Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research
Suggested Citation: Suggested Citation
Aboy, Mateo and Liddicoat, Johnathon and Liddell, Kathleen and Jordan, Matthew and Crespo, Cristina, After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature? (September 11, 2017). 35 Nature Biotechnology 820-825, Available at SSRN: https://ssrn.com/abstract=3176414
Here is the Coronavirus
related research on SSRN
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
